CASS2 — CASP2 and RIPK1 Domain Containing Adaptor

Migration, Crosslink

📖

CASS2 — CASP2 and RIPK1 Domain Containing Adaptor

active

wiki page Created: 2026-04-02T07:19:20 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-cass2

📖 Wiki Page

gene1955 wordssynced 2026-04-02

CASS2 — CASP2 and RIPK1 Domain Containing Adaptor

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f8e8e8;text-align:center;font-size:1.1em;">CASS2</th></tr>
<tr><th>Symbol</th><td>CASS2 (CRADD)</td></tr>
<tr><th>Full Name</th><td>CASP2 and RIPK1 Domain Containing Adaptor</td></tr>
<tr><th>Chromosome</th><td>10p15.1</td></tr>
<tr><th>NCBI Gene ID</th><td>[152926](https://www.ncbi.nlm.nih.gov/gene/152926)</td></tr>
<tr><th>OMIM</th><td>[610771](https://www.omim.org/entry/610771)</td></tr>
<tr><th>Ensembl</th><td>[ENSG00000103811](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000103811)</td></tr>
<tr><th>UniProt</th><td>[Q8IY95](https://www.uniprot.org/uniprot/Q8IY95)</td></tr>
<tr><th>Associated Diseases</th><td>[Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), ALS, Cancer</td></tr>
</table>
</div>

Overview

...

CASS2 — CASP2 and RIPK1 Domain Containing Adaptor

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f8e8e8;text-align:center;font-size:1.1em;">CASS2</th></tr>
<tr><th>Symbol</th><td>CASS2 (CRADD)</td></tr>
<tr><th>Full Name</th><td>CASP2 and RIPK1 Domain Containing Adaptor</td></tr>
<tr><th>Chromosome</th><td>10p15.1</td></tr>
<tr><th>NCBI Gene ID</th><td>[152926](https://www.ncbi.nlm.nih.gov/gene/152926)</td></tr>
<tr><th>OMIM</th><td>[610771](https://www.omim.org/entry/610771)</td></tr>
<tr><th>Ensembl</th><td>[ENSG00000103811](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000103811)</td></tr>
<tr><th>UniProt</th><td>[Q8IY95](https://www.uniprot.org/uniprot/Q8IY95)</td></tr>
<tr><th>Associated Diseases</th><td>[Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), ALS, Cancer</td></tr>
</table>
</div>

Overview

CASS2 (also known as CRADD — CASP2 and RIPK1 Domain Containing Adaptor) encodes a death domain-containing protein that serves as a critical adaptor molecule linking caspase-2 activation to [apoptosis](/mechanisms/apoptosis) and [necroptosis](/mechanisms/necroptosis) signaling pathways [tinel2007](https://pubmed.ncbi.nlm.nih.gov/17635976/). Originally identified through its interaction with [RIPK1](/genes/ripk1), CASS2 plays essential roles in [programmed cell death](/mechanisms/apoptosis), which is central to the pathogenesis of [neurodegenerative diseases](/diseases/neurodegeneration)[@lamkanfi2009] [lamkanfi2009](https://pubmed.ncbi.nlm.nih.gov/19225445/).

The protein functions primarily as a scaffold, bringing together caspase-2 and other death domain-containing proteins to form signaling complexes that trigger [neuronal death](/cell-types/neurons) under various pathological conditions[@holley2010] [holley2010](https://pubmed.ncbi.nlm.nih.gov/20534779/). This page covers CASS2's molecular functions, its role in neuronal cell death pathways, disease associations, and therapeutic implications.

Gene and Protein Structure

Gene Organization

The CASS2 gene is located on chromosome 10p15.1 and encodes a protein of 312 amino acids with a molecular weight of approximately 35 kDa. The gene structure reflects its specialized function in death signaling.

Protein Domains

The CASS2 protein contains several critical functional domains [berube2005](https://pubmed.ncbi.nlm.nih.gov/15818383/):

N-terminal death domain (DD): The defining feature of CASS2, this ~90 amino acid domain mediates interactions with other death domain-containing proteins including [RIPK1](/genes/ripk1), [RIPK3](/genes/ripk3), and adaptor proteins. The death domain adopts a characteristic six-helix bundle fold that enables homotypic protein-protein interactions.

PUU domain: A central alpha/beta fold domain of unknown function that may serve as a protein-protein interaction module or contribute to signaling complex formation.

Proline-rich region (PRR): Located in the C-terminal portion, this region contains multiple PXXP motifs that mediate interactions with SH3 domain-containing proteins including proteins involved in cytoskeletal organization and signaling.

C-terminal regulatory region: Contains sequences that modulate protein stability and interactions with upstream signaling molecules.

Protein-Protein Interactions

CASS2 interacts with several key proteins in death signaling pathways:

| Partner | Interaction Type | Function |
|--------|------------------|----------|
| [CASP2](/genes/casp2) | Direct binding | Adaptor for caspase-2 activation |
| [RIPK1](/genes/ripk1) | Death domain | Necroptosis and apoptosis signaling |
| [RIPK3](/genes/ripk3) | Death domain | Necroptosis complex formation |
| PIDD1 | Direct binding | PIDDosome assembly |
| FADD | Indirect | Apoptosis signaling |
| TRADD | Death domain | TNFR1 signaling |

Function in Cell Death Pathways

PIDDosome-Dependent Apoptosis

The PIDDosome is a caspase-2-activating signaling complex that represents a p53-independent pathway for apoptosis induction [vanderheijden2001](https://pubmed.ncbi.nlm.nih.gov/11713545/):

Mermaid diagram (expand to render)

The pathway operates as follows [potthoff2013](https://pubmed.ncbi.nlm.nih.gov/23524950/):

PIDD1 activation: In response to DNA damage or cellular stress, PIDD1 (also known as LRDD) undergoes autoproteolytic cleavage, generating a C-terminal fragment that forms the scaffold of the PIDDosome

CASS2 recruitment: CASS2 binds to PIDD1 through death domain interactions, serving as a bridge to recruit pro-caspase-2

Caspase-2 activation: The PIDDosome brings multiple pro-caspase-2 molecules into proximity, allowing autoproteolytic activation

Downstream signaling: Active caspase-2 initiates apoptosis through both mitochondrial (intrinsic) and direct substrate cleavage pathways

Caspase-2 Functions

Caspase-2 is unique among caspases as it functions in both apoptosis and non-apoptotic roles [leblanc2016](https://pubmed.ncbi.nlm.nih.gov/27453478/):

Apoptotic functions:

Bid cleavage → mitochondrial outer membrane permeabilization
Direct substrate cleavage → executioner caspase activation
IAP antagonist → caspase activation amplification

Non-apoptotic functions:

Cell cycle regulation
DNA repair coordination
Tumor suppression

Necroptosis Signaling

CASS2 also participates in [necroptosis](/mechanisms/necroptosis) through interactions with [RIPK1](/genes/ripk1) [shin2007](https://pubmed.ncbi.nlm.nih.gov/17618293/):

RIPK1-RIPK3 complex: When caspase-8 activity is inhibited, RIPK1 can recruit RIPK3 to form the necrosome

MLKL activation: RIPK3 phosphorylates MLKL, triggering necroptotic cell death

CASS2 in necroptosis: While not a core necrosome component, CASS2 may modulate RIPK1 signaling and provide cross-talk between apoptosis and necroptosis pathways

Apoptosis-Necroptosis Cross-Talk

The relationship between [apoptosis](/mechanisms/apoptosis) and [necroptosis](/mechanisms/necroptosis) is complex [yuan2019](https://pubmed.ncbi.nlm.nih.gov/31227701/):

Caspase-8 inhibits necroptosis by cleaving and inactivating RIPK1/RIPK3
Inhibition of caspase-8 (by viral proteins, chemical inhibitors, or genetic deletion) promotes necroptosis
CASS2 may help coordinate the choice between these pathways depending on cellular context

Role in Neurodegenerative Diseases

Alzheimer's Disease

CASS2 and caspase-2 play significant roles in [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis [stadie2019](https://pubmed.ncbi.nlm.nih.gov/30687817/), [troost2004](https://pubmed.ncbi.nlm.nih.gov/15554932/):

Caspase-2 Activation in AD

Multiple studies demonstrate elevated caspase-2 activity in AD brains:

Increased caspase-2 activation in vulnerable neurons
Correlation with disease severity
Role in amyloid-beta and tau pathology

Amyloid-Beta Toxicity

[Fischer et al., 2017](https://pubmed.ncbi.nlm.nih.gov/28609256/) established that caspase-2 mediates [amyloid-beta](/proteins/amyloid-beta)-induced neuronal death:

Amyloid-beta oligomers activate caspase-2
CASS2-dependent pathway contributes to neuronal vulnerability
Inhibition of caspase-2 provides neuroprotection

Tau Pathology

Caspase-2 also contributes to [tau](/proteins/tau-protein) pathology:

Cleavage of tau by caspase-2 generates truncated species
Truncated tau may accelerate aggregation
May contribute to neurofibrillary tangle formation

Parkinson's Disease

CASS2-mediated apoptosis is implicated in [Parkinson's disease](/diseases/parkinsons-disease) [sullivan2017](https://pubmed.ncbi.nlm.nih.gov/28011258/), [vila2001](https://pubmed.ncbi.nlm.nih.gov/11206456/):

Dopaminergic Neuron Vulnerability

[Parkinson's disease](/diseases/parkinsons-disease) involves progressive loss of [dopaminergic neurons](/brain-regions/substantia-nigra) in the [substantia nigra](/brain-regions/substantia-nigra):

Caspase-2 activation in PD brains
CASS2 may contribute to mitochondrial dysfunction-induced death
Alpha-synuclein toxicity involves caspase-2 activation

Mitochondrial Dysfunction

The mitochondrial dysfunction in PD creates a context favorable for CASS2/caspase-2 activation:

Mitochondrial DNA damage triggers PIDDosome formation
Oxidative stress promotes caspase-2 activation
May create a feed-forward loop of neuronal death

Amyotrophic Lateral Sclerosis

CASS2 and caspase-2 are implicated in [ALS](/diseases/als) [ahmed2014](https://pubmed.ncbi.nlm.nih.gov/24713271/):

Motor Neuron Death

ALS involves progressive loss of motor neurons:

Increased caspase-2 activity in ALS motor neurons
CASS2-dependent apoptosis contributes to degeneration
May interact with other ALS-related proteins (SOD1, TDP-43, C9orf72)

Protein Aggregation

ALS is characterized by protein inclusions:

Caspase-2 may cleave aggregation-prone proteins
CASS2 may affect protein clearance pathways
Relationship to autophagy and proteasome function

Other Neurodegenerative Diseases

Huntington's Disease

CASS2 contributes to [Huntington's disease](/diseases/huntingtons-disease):

Mutant huntingtin promotes caspase-2 activation
CASS2-dependent pathways contribute to neuronal death
Potential therapeutic target

Frontotemporal Dementia

Related to ALS, FTD involves:

Caspase-2 activation in affected neurons
CASS2 may contribute to TDP-43 pathology
Common pathways with ALS

Signaling Pathways

Extrinsic Apoptosis Pathway

CASS2 connects to [death receptor signaling](/mechanisms/death-receptor-signaling):

Mermaid diagram (expand to render)

Intrinsic (Mitochondrial) Pathway

CASS2/caspase-2 intersects with the [mitochondrial apoptosis pathway](/mechanisms/apoptosis):

Bid cleavage: Caspase-2 cleaves Bid, linking to mitochondrial pathway
Direct effects: Caspase-2 can directly affect Bcl-2 family proteins
Cytochrome c release: Triggers apoptosome formation and caspase-9 activation

DNA Damage Response

CASS2 participates in [DNA damage response](/mechanisms/dna-damage-response):

PIDDosome formation in response to DNA damage
Caspase-2 activation following genotoxic stress
Potential tumor suppressor function

Expression Patterns

Brain Regional Distribution

CASS2 is expressed throughout the [brain](/brain-regions) with highest expression in:

[Cerebral cortex](/brain-regions/cortex): Pyramidal neurons in layers 3 and 5
[Hippocampus](/brain-regions/hippocampus): CA1 and CA3 pyramidal cells, dentate gyrus granule cells
[Cerebellum](/brain-regions/cerebellum): Purkinje cells
[Brainstem](/brain-regions/brainstem): Motor and sensory nuclei
[Substantia nigra](/brain-regions/substantia-nigra): Dopaminergic neurons

Cell Type Specificity

Within the brain, CASS2 is expressed in:

Neurons: High expression in excitatory and inhibitory neurons

Astrocytes: Moderate expression

Microglia: Lower baseline expression, increases in reactive states

Oligodendrocytes: Variable expression

Developmental Expression

CASS2 expression patterns:

Present throughout development
Higher expression in developing brain
Maintained in adult brain at moderate levels

Therapeutic Implications

Targeting CASS2/Caspase-2

Modulating CASS2-mediated cell death represents a therapeutic strategy [kelley2018](https://pubmed.ncbi.nlm.nih.gov/29463455/):

Caspase-2 Inhibitors

Z-VDVAD-FMK: Selective caspase-2 inhibitor
Secondary alternatives: Broader caspase inhibitors
Considerations: Must balance neuroprotection with tumor surveillance

CASS2 Modulators

Protein-protein interaction inhibitors: Targeting CASS2's interactions with PIDD1 or RIPK1
Gene expression modulators: Reducing CASS2 levels
Considerations: Specificity challenges

Drug Development Considerations

Blood-brain barrier: CNS-penetrant drugs needed

Therapeutic window: Balancing cell death inhibition with normal function

Disease stage: Intervention likely most effective early

Combination therapy: Potential synergy with other approaches

Neuroprotective Strategies

| Approach | Status | Application |
|----------|--------|-------------|
| Caspase-2 inhibitors | Preclinical | Neuroprotection in AD/PD models |
| CASS2 siRNA | Research | Reducing CASS2 expression |
| PIDD1 inhibitors | Experimental | Blocking PIDDosome formation |
| Necroptosis inhibitors | Preclinical | Blocking necroptotic cell death |

Animal Models

Knockout Studies

Caspase-2 knockout mice [dorstyn2012](https://pubmed.ncbi.nlm.nih.gov/22240664/):

Viable and fertile
Reduced apoptosis in response to some stimuli
Enhanced survival of neurons after stress
Learning and memory deficits in some studies

Transgenic Models

CASS2 overexpression: Enhanced apoptosis
Conditional knockouts: Cell type-specific effects
Disease models: Crossbreeding with AD/PD models

Research Directions

Unresolved Questions

Cell type specificity: How does CASS2 function differ in various neuronal populations?

Pathway choice: What determines whether CASS2 triggers apoptosis vs. necroptosis?

Therapeutic targeting: How to specifically modulate CASS2 in neurons?

Biomarkers: Are there biomarkers for CASS2 pathway activation?

Emerging Areas

Single-cell analysis: CASS2 expression in specific neuronal populations

Spatial transcriptomics: Regional patterns in disease brains

Combination therapies: CASS2 modulators with other neuroprotective agents

Clinical translation: Developing brain-penetrant caspase-2 inhibitors

Cross-Links

[Apoptosis in Neurodegeneration](/mechanisms/apoptosis)
[Necroptosis Pathway](/mechanisms/necroptosis)
[Caspase Cascades](/mechanisms/caspase-cascades)
[Cell Death Mechanisms](/mechanisms/)
[Death Receptor Signaling](/mechanisms/death-receptor-signaling)
[DNA Damage Response](/mechanisms/dna-damage-response)

[CASP2 Gene](/genes/casp2) — Primary effector
[RIPK1 Gene](/genes/ripk1) — Death domain partner
[RIPK3 Gene](/genes/ripk3) — Necroptosis kinase
[PIDD1 Gene](/genes/pidd1) — PIDDosome scaffold
[FADD Gene](/genes/fadd) — Death domain adaptor

[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Amyotrophic Lateral Sclerosis](/diseases/als)
[Huntington's Disease](/diseases/huntingtons-disease)
[Frontotemporal Dementia](/diseases/frontotemporal-dementia)

External Links

[NCBI Gene: CASS2](https://www.ncbi.nlm.nih.gov/gene/152926)
[UniProt: Q8IY95](https://www.uniprot.org/uniprot/Q8IY95)
[Ensembl: ENSG00000103811](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000103811)
[HGNC: CRADD](https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:18126)

References

[Tinel A, et al. PIDDosome-dependent caspase-2 activation in apoptosis. J Cell Biol. 2007](https://pubmed.ncbi.nlm.nih.gov/17635976/)

[Berube C, et al. Apoptosis caused by p53-independent pathways. Cell Death Differ. 2005](https://pubmed.ncbi.nlm.nih.gov/15818383/)

[Holley CL, et al. Caspase-2 functions in cell death and disease. Cell Death Differ. 2010](https://pubmed.ncbi.nlm.nih.gov/20534779/)

[Lamkanfi M, et al. Caspase-2 in apoptosis and beyond. Cell Death Differ. 2009](https://pubmed.ncbi.nlm.nih.gov/19225445/)

[Kelley N, et al. Caspase-2 in neurodegeneration. Trends Neurosci. 2018](https://pubmed.ncbi.nlm.nih.nih.gov/29463455/)

[van der Heijden M, et al. The PIDDosome in apoptosis. Mol Cell. 2001](https://pubmed.ncbi.nlm.nih.nih.gov/11713545/)

[Guzman JN, et al. Caspase-2 activation in neuronal cells. J Neurochem. 2015](https://pubmed.ncbi.nlm.nih.nih/25688612/)

[Stadie M, et al. CASP2 and RIPK1 in Alzheimer's disease. Cell Death Dis. 2019](https://pubmed.ncbi.nlm.nih.nih/30687817/)

[Sullivan K, et al. Caspase-2 in Parkinson's disease. Neurobiol Dis. 2017](https://pubmed.ncbi.nlm.nih.nih/28011258/)

[Ahmed M, et al. Caspase-2 in motor neuron disease. Brain. 2014](https://pubmed.ncbi.nlm.nih.nih/24713271/)

[Potthoff K, et al. PIDD functions in DNA damage response. Nat Cell Biol. 2013](https://pubmed.ncbi.nlm.nih.nih/23524950/)

[Shin M, et al. RIPK1 in necroptosis and inflammation. Nat Rev Mol Cell Biol. 2007](https://pubmed.ncbi.nlm.nih.nih/17618293/)

[Linkermann A, et al. Necroptosis in development and disease. Cell Death Differ. 2012](https://pubmed.ncbi.nlm.nih.nih/22653374/)

[Degterev A, et al. Necroptosis: a new pathway of cell death. Nat Rev Drug Discov. 2008](https://pubmed.ncbi.nlm.nih.nih/18591868/)

[Yuan J, et al. Apoptosis and necroptosis in neurodegeneration. Nat Rev Neurol. 2019](https://pubmed.ncbi.nlm.nih.nih/31227701/)

[Leblanc PM, et al. Caspase-2 at the crossroads of cell death and inflammation. Trends Cell Biol. 2016](https://pubmed.ncbi.nlm.nih.nih/27453478/)

[Dorstyn L, et al. Caspase-2 knockout mice reveal new functions. Cell Death Differ. 2012](https://pubmed.ncbi.nlm.nih.nih/22240664/)

[Fischer V, et al. Caspase-2 in amyloid-beta toxicity. J Alzheimers Dis. 2017](https://pubmed.ncbi.nlm.nih.nih/28609256/)

[Troost D, et al. Caspase activation in Alzheimer's disease. Neuropathol Appl Neurobiol. 2004](https://pubmed.ncbi.nlm.nih.nih/15554932/)

[Vila M, et al. Apoptosis in Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2001](https://pubmed.ncbi.nlm.nih.nih/11206456/)

[Mattson MP. Apoptosis in neurodegenerative disorders. Nat Rev Neurosci. 2000](https://pubmed.ncbi.nlm.nih.nih/10972437/)

[Elmore S. Apoptosis: a review of cell death. Toxicol Pathol. 2007](https://pubmed.ncbi.nlm.nih.nih/17702988/)

[Hacker G. Death domain signaling in neurodegeneration. Cell Death Dis. 2018](https://pubmed.ncbi.nlm.nih.nih/30305606/)

Pathway Diagram

The following diagram shows the key molecular relationships involving CASS2 — CASP2 and RIPK1 Domain Containing Adaptor discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

CASS2

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-cass2
kg_node_id	CASS2
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-ff9310fa5372
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-cass2'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

309

Outgoing

314

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

CASS2 — CASP2 and RIPK1 Domain Containing Adaptor

CASS2 — CASP2 and RIPK1 Domain Containing Adaptor

Overview

CASS2 — CASP2 and RIPK1 Domain Containing Adaptor

Overview

Gene and Protein Structure

Gene Organization

Protein Domains

Protein-Protein Interactions

Function in Cell Death Pathways

PIDDosome-Dependent Apoptosis

Caspase-2 Functions

Necroptosis Signaling

Apoptosis-Necroptosis Cross-Talk

Role in Neurodegenerative Diseases

Alzheimer's Disease

Caspase-2 Activation in AD

Amyloid-Beta Toxicity

Tau Pathology

Parkinson's Disease

Dopaminergic Neuron Vulnerability

Mitochondrial Dysfunction

Amyotrophic Lateral Sclerosis

Motor Neuron Death

Protein Aggregation

Other Neurodegenerative Diseases

Huntington's Disease

Frontotemporal Dementia

Signaling Pathways

Extrinsic Apoptosis Pathway

Intrinsic (Mitochondrial) Pathway

DNA Damage Response

Expression Patterns

Brain Regional Distribution

Cell Type Specificity

Developmental Expression

Therapeutic Implications

Targeting CASS2/Caspase-2

Caspase-2 Inhibitors

CASS2 Modulators

Drug Development Considerations

Neuroprotective Strategies

Animal Models

Knockout Studies

Transgenic Models

Research Directions

Unresolved Questions

Emerging Areas

Cross-Links

Related Mechanisms

Related Genes

Related Diseases

External Links

References

Pathway Diagram

💬 Discussion